Cybersäkerhet: vad innebär NIS2-direktivet för life science-företag?
-
IT-attacker blir allt vanligare och utgör ett växande hot mot såväl offentliga verksamheter som små och stora företag.
Leap secured for integrating biologics into topical skin creams
Niclas Roxhed, one of the founders of KTH Innovation's spinoff Morningstar Therapeutics, has just secured a 6.1 million SEK research grant from the LEO Foundation. This funding will advance the development of their groundbreaking spiked microneedle spheres – here used to topically deliver nucleic acids to reprogram skin cells and treating atopic eczema in a model.
New report on life science trends: Healthy Longevity, Precision Medicine, and Next-Generation Therapeutics
What groundbreaking movements are shaping life sciences today? How do these advancements influence our society, healthcare systems, and lifestyles now and in the future? Stockholm Science City has unveiled a report delving into healthy longevity, precision medicine, and next-generation therapeutics, shedding light on key trends in the fields.
“Why innovation districts matter”
A summit that brings together over 200 brilliant minds to discuss how innovation districts contribute to growth and attraction. It’s the summit “Navigating the Future of Innovation Districts”, where experiences and ideas will be shared to reach a new level for innovation districts.
Trends in Metabolic Studies of Pharmaceutical Drugs
Datum
-
Plats
Arr: Apotekarsocieteten, Stockholm.
Navigating the Future of Innovation Districts
Stockholm’s 1st Innovation District Summit
A summit that brings together brilliant minds to discuss how innovation districts contribute to growth and attraction. Experiences and ideas will be shared to reach a new level for innovation districts.
"Vi måste välja rätt väg inom life science"
JENNI NORDBORG: Jag överdriver knappast när jag påstår att just nu står Stockholms, Sveriges och hela Europas framtid inom life science på spel. Vi måste få EUs regeringar och Bryssels byråkrater att välja rätt väg – den som leder till att företagens forskningsinvesteringar ökar, att nya läkemedel forskas fram och utvecklas inom EU och att life science-kluster, som det vi har i Stockholm, kan fortsätta utvecklas.
Resultat från FOKUS Patients enkät
FOKUS Patient® är en mötesplats för hälso- och sjukvårdsfrågor och life science. I mars genomförde de för tredje gången en enkät till patient- och funktionshinderrörelsen i Sverige. Frågorna rörde information, organisation, ekonomi, kommunikation och utbildning-kunskap.
Sessions for Navigating the Future of Innovation Districts
The summit will take place on September 26 in Stockholm. A welcome reception and dinner will be held on September 25 at The City Hall. There will be four sessions during the summit:
1. The Value of Place
Why location matters to the frontier economy, and the changing physical spaces, design, environment and infrastructure ingredients that spark creativity and connection in innovation districts.
2. Governance and Community
To explore how collaborative leadership and governance enable an innovation district to grow and evolve for the benefit of its stakeholders. The effect of different arrangements and leadership styles on incentivising collaboration at all levels.
3. The Ecosystem Secret Sauce
This session will explore how different organisations contribute to the local innovation ecosystem, with examples from businesses, educational institutions, and support services. What tools and tactics encourage real knowledge sharing, risk-taking and the cross-pollination of ideas?
4. The Future
Scenarios innovation districts should expect and prepare for in future.
